Merck's Deal For Terns And Its Stellar CML Drug Candidate Looks Like Good Business (MRK)

If you are interested in keeping up to date with stocks making moves within the biotech, pharma, and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?Today, news has broken that Terns Pharmaceuticals, Inc. ( TERN ), a Foster City, California-based biotech, is set to be acquired by the Pharma giant Merck & Co., Inc. ( MRK ), inEdmund Ingham is a biotech consulta ...